There are no products listed under this category.
PLPP2
PLPP2 (phospholipid phosphatase 2, also known as PAP-2c, LPP2 and PPAP2C) is a magnesium-independent membrane phospholipid phosphatase. It dephosphorylates bioactive glycerolipid and sphingolipid phosphate esters and may shape lipid-mediated signal transduction inside the cell. Browse Assay Genie's current range of PLPP2 research reagents below, or read on for the biology behind the target.
PLPP2 catalyses the dephosphorylation of a variety of glycerolipid and sphingolipid phosphate esters, including phosphatidate (PA), lysophosphatidate (LPA), sphingosine 1-phosphate (S1P) and ceramide 1-phosphate (C1P). It also acts on N-oleoyl ethanolamine phosphate, a potential physiological compound. Its activity does not require magnesium. It has no apparent extracellular phosphatase activity, so it most probably acts intracellularly. By removing phosphate from these bioactive lipid mediators, it produces new bioactive compounds and may regulate signal transduction in different cellular processes. For example, its phospholipid phosphatase activity indirectly regulates the G1/S phase transition of the cell cycle.
The PLPP2 protein belongs to the PA-phosphatase related phosphoesterase family and to the HGNC group of phospholipid phosphatases. Like other phosphatidic acid phosphatases (PAPs), it converts phosphatidic acid to diacylglycerol. This function is relevant to de novo glycerolipid synthesis and to receptor-activated signal transduction mediated by phospholipase D. The protein is similar to phosphatidic acid phosphatase type 2A and type 2B. All three contain six transmembrane regions and a consensus N-glycosylation site. UniProt places PLPP2 in the cell membrane, early endosome membrane and endoplasmic reticulum membrane, and it has been shown to possess membrane-associated PAP activity.
The PLPP2 gene was formerly called PPAP2C, and the protein was named phosphatidic acid phosphatase type 2C (PAP-2c, LPP2). Three alternatively spliced transcript variants encoding distinct isoforms have been reported. Mouse and rat both carry a Plpp2 ortholog.
PLPP2 dephosphorylates PA, LPA, S1P and C1P, so it is studied for how lipid mediators are converted into new bioactive compounds.
Its phospholipid phosphatase activity indirectly regulates the G1/S phase transition, making it a point of interest in cell cycle control.
As a phosphatidic acid phosphatase, PLPP2 converts phosphatidic acid to diacylglycerol, linking it to de novo glycerolipid synthesis.
PLPP2 localises to the cell, early endosome and endoplasmic reticulum membranes, supporting work on intracellular lipid phosphatase activity.
PLPP2 is a magnesium-independent phospholipid phosphatase. It dephosphorylates PA, LPA, S1P and C1P, and it has no apparent extracellular activity, so it most probably acts intracellularly. It may regulate signal transduction and indirectly influences the G1/S cell cycle transition.
PLPP2 is also called PAP-2c, LPP2 and PPAP2C, and was previously named phosphatidic acid phosphatase type 2C. NCBI Gene reports three alternatively spliced transcript variants that encode distinct isoforms.
PLPP2 is similar to phosphatidic acid phosphatase types 2A and 2B. All three have six transmembrane regions and a consensus N-glycosylation site. Mouse and rat each have a Plpp2 ortholog; check the datasheet of any product for its validated reactivity.
Other phospholipid phosphatase family members and related lipid-signalling targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43688; product specifications from Assay Genie datasheets.
There are no products listed under this category.